Acadia Healthcare Sees FY24 Adj. EPS $3.45-$3.65 Vs $3.49 Est.; Revenue $3.180B-$3.22B Vs $3.202B Est.
Portfolio Pulse from Benzinga Newsdesk
Acadia Healthcare has provided its financial guidance for FY24, projecting adjusted EPS between $3.45 and $3.65, compared to the estimated $3.49. The company also expects revenue to be in the range of $3.180 billion to $3.22 billion, slightly below the estimated $3.202 billion.
July 31, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Acadia Healthcare's FY24 guidance shows a positive outlook for adjusted EPS, but revenue projections are slightly below estimates. This mixed guidance may lead to moderate volatility in the stock price.
The adjusted EPS guidance is above the estimate, which is a positive sign. However, the revenue projection is slightly below the estimate, which could offset some of the positive sentiment. Overall, the mixed guidance may result in moderate volatility in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100